Physician profile

Sheela Choubey

Obstetrics & Gynecology · Piscataway, NJ

NPI 1023083441

$364.15

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$94.42

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Exeltis, USA INC. $97.26 2019-2023 Nuvessa
Abbvie INC. $81.74 2021-2022
Hologic Sales and Service, LLC $66.56 2021-2023 Aptima
Sumitomo Pharma America, INC. $27.72 2023 Myfembree
Mayne Pharma Commercial LLC $20.04 2023-2024
Myovant Sciences INC. $18.11 2022
Bayer Healthcare Pharmaceuticals INC. $15.79 2019
Agile Therapeutics, INC. $12.69 2022
Avion Pharmaceuticals $12.17 2021
Coopersurgical, INC. $12.07 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sheela Choubey

$364.15

in general payments reported 2019-2025

Years
2019-2024
Top company
Exeltis, USA INC.

https://glasscript.com/doctor/762656/sheela-choubey

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.